Recordati Overview

  • Founded
  • 1926
Founded
  • Status
  • Public
  • Employees
  • 4,362
Employees
  • Stock Symbol
  • REC
Stock Symbol
  • Investments
  • 20
  • Share Price
  • $53.38
  • (As of Friday Closing)

Recordati General Information

Description

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Contact Information

Website
www.recordati.com
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
MIL
Primary Office
  • Via Matteo Civitali, 1
  • 20148 Milan
  • Italy
+39 02 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Recordati Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$53.38 $53.21 $44.02 - $56.88 $11B 206M 317K $1.89

Recordati Financials Summary

In Thousands,
USD 		TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 12,167,043 12,480,515 9,142,629 7,751,754
Revenue 1,636,244 1,651,582 1,658,847 1,595,727
EBITDA 654,159 646,138 601,557 586,581
Net Income 388,738 404,651 412,879 368,624
Total Assets 3,326,340 3,335,245 3,146,485 2,472,278
Total Debt 1,302,864 1,305,067 1,232,809 901,550
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Recordati Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Recordati‘s full profile, request access.

Request a free trial

Recordati Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promot
Pharmaceuticals
Milan, Italy
4,362 As of 2020
0.000 0000-00-00
000000000000

00000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000

000000 0

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
000000000000000
Tokyo, Japan
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Recordati Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland 000000 000000000000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
000000 Corporation Maharashtra, India 0000
000000 00000 Corporation Mumbai, India 0000
You’re viewing 5 of 42 competitors. Get the full list »

Recordati Executive Team (9)

Name Title Board Seat Contact Info
Andrea Recordati Chief Executive Officer
Luigi La Corte Chief Financial Officer
Marianne Tatschke Director, Investor Relations & Corporate Communications
Gabriele Finzi Vice President, Corporate Development & Licensing
Alberto Recordati Ph.D Chairman
You’re viewing 5 of 9 executive team members. Get the full list »

Recordati Board Members (2)

Name Representing Role Since
0000000 000000000 00.0 Recordati Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Recordati Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Recordati Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Recordati‘s full profile, request access.

Request a free trial

Recordati Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 23-Oct-2019 000000000 00000 00 00000 Buildings and Property 0000000 000000000 00.0
000000000 31-Dec-2018 000000000000000000 000.00 Medical Supplies 000000 000000000
0000000 00000 11-Jun-2018 000000000000000000 00000 Food Products 0000000 000000000 00.0
00000 00000 000000 18-Dec-2017 000000000 00000 00 Buildings and Property 000000 000000000
AstraZeneca (Seloken/Seloken ZOK/Logimax) 25-May-2017 Corporate Asset Purchase 00000 Buildings and Property 000000 000000000
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Recordati Subsidiaries (7)

Company Name Industry Location Founded
Pro Farma Distributors/Wholesale (B2C) Baar, Switzerland 1995
0000000 00000 Food Products Milan, Italy 0000
000000000 Medical Supplies Boulogne, France 0000
000000 000000 Pharmaceuticals Puteaux, France 0000
000000 000000 Pharmaceuticals Ariana, Tunisia 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Recordati Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000000 01-Jan-1986 000000000000000000 Completed
  • 000000000
To view Recordati’s complete exits history, request access »